Ruisch Anika, Ntopi Simon, Mathur Ishani, Conlin Maeve, McCaffrey Anna, Walker Damian G, Suharlim Christian
Management Sciences for Health, 4201 Wilson Boulevard Suite 500, Arlington, VA, 22203, USA.
Management Sciences for Health, Lilongwe, Malawi.
Cost Eff Resour Alloc. 2025 Jul 22;23(1):36. doi: 10.1186/s12962-025-00610-2.
While COVID-19 vaccines became available in late 2020, low-income countries (LICs) faced challenging COVID-19 vaccine distribution efforts in terms of both a delayed and scarce vaccine supply and barriers reaching the target populations. The cost of delivering COVID-19 vaccines in LICs is uncertain, which complicates planning and budgeting for country leadership as well as major funders. In the absence of such data, a global model was developed by the COVAX Working Group on Delivery Costing using data on the costs of similar immunization campaigns and assumptions. This study has two objectives, firstly to estimate the costs of delivering COVID-19 vaccine delivery using primary data collected in Malawi, and secondly comparing these estimates to modeled estimates based on secondary data, to contribute to a growing evidence base on the cost of the COVID-19 vaccination delivery in LICs.This retrospective study used a bottom-up method to estimate the financial and economic costs. Data were collected from health facilities and health posts via a COVID-19 cost survey. The data sources included existing records and interviews with relevant districts and facility staff. Twenty representative vaccine delivery sites were purposively selected across four districts. We focused on major cost drivers that contributed to the highest proportion and variability in delivery costs.The total financial cost of COVID-19 vaccine delivery in 20 facilities across four districts in Malawi (from April 1, 2021-March 31, 2022) was US$ 322,786. During that period, the 20 facilities delivered 70,947 vaccines. The financial cost per dose delivered was US$ 4.55. Considering the reallocation of existing staff time toward COVID-19 vaccination, volunteer opportunity costs, and donated vehicles, the economic cost per dose delivered was nearly four times greater at US$ 16.15. The economic cost of labor was estimated at US$ 10.75 per dose delivered and accounts for two-thirds of the total economic cost.This study is the first to provide evidence on the cost of COVID-19 vaccine delivery in Malawi. The financial cost of delivering the COVID-19 vaccine in twenty health facilities across 4 districts in Malawi, at US$ 4.55 [US$ 3.23- US$ 6.33] per dose delivered. We observed a large amount of labor reallocation towards COVID-19 vaccination.
虽然2020年末就有了新冠疫苗,但低收入国家在新冠疫苗分发工作上面临挑战,疫苗供应延迟且稀缺,同时在覆盖目标人群方面也存在障碍。在低收入国家提供新冠疫苗的成本尚不确定,这给国家领导层以及主要资助者的规划和预算编制带来了复杂性。在缺乏此类数据的情况下,新冠疫苗全球免疫接种计划交付成本工作组利用类似免疫接种活动成本的数据和假设,开发了一个全球模型。本研究有两个目标,一是利用在马拉维收集的原始数据估算新冠疫苗交付成本,二是将这些估算值与基于二手数据的模型估算值进行比较,以为低收入国家新冠疫苗接种交付成本这一不断增长的证据库做出贡献。这项回顾性研究采用自下而上的方法来估算财务成本和经济成本。通过新冠成本调查从卫生设施和卫生站收集数据。数据来源包括现有记录以及与相关地区和设施工作人员的访谈。在四个地区有目的地选择了20个有代表性的疫苗交付点。我们关注导致交付成本占比最高且差异最大的主要成本驱动因素。2021年4月1日至2022年3月31日期间,马拉维四个地区20个设施的新冠疫苗交付总财务成本为322,786美元。在此期间,这20个设施共交付了70,947剂疫苗。每剂交付的财务成本为4.55美元。考虑到将现有工作人员时间重新分配用于新冠疫苗接种、志愿者机会成本和捐赠车辆,每剂交付的经济成本高出近四倍,为16.15美元。每剂交付的劳动力经济成本估计为10.75美元,占总经济成本的三分之二。本研究首次提供了马拉维新冠疫苗交付成本的证据。在马拉维4个地区的20个卫生设施中交付新冠疫苗的财务成本为每剂4.55美元[3.23美元 - 6.33美元]。我们观察到大量劳动力被重新分配用于新冠疫苗接种。